BUSCOPAN

DEFINATION

Buscopan is a medication that contains

hyoscine butylbromide as its active ingredient. It is

commonly used to treat abdominal cramps and

spasms associated with conditions like irritable bowel

syndrome (IBS) and other gastrointestinal issues.

 GENETIC NAME TRADE NAME

• HYOSCINE –N – • BUSCOPAN
BUTYLBROMIDE
• BUSCOPAN
• HYOSCINE
PLUS
BUTYLBROMIDE
 DOSE + ROUTE
TABLETE 10 mg INJECTION 20mg/ML
• INTRAVENOUS
ORAL
• INTRAMUSCULAR
 ACTION
Inhibits acetylcholine at receptor sites
in autonomic nervous system, which controls
secretions free acids to stomach blocks central
muscarinic receptors, which decreases involuntary
movements
 INDICATION
It is an antispasmodic used for
gastrointestinal tract spasm, spasm
TABLET :-
and dyskinesia of the biliary
system and genitourinary tract
spasm.
 • Acute GI,
• Biliary and genitourinary spasm,
• Include biliary and renal colic,
INJECTION :- • Dysmenorrhea.
• Parenterally also as an aid in
diagnostic and therapeutic procedures,
e.g. gastroduodenal endoscopy,
radiology
 CONTRAINDICATION
• HYPERSENSITIVITY

• GLUCOMA

• MYASTHENIA GRAVIS ( a chronic neuromuscular disease

that cause weakness in the voluntary muscles

• This medicine should not take with any medicine

 WHAT PREGNANCY RISK CATEGORY IS
BUSCOPAN?
Buscopan is not thought to be harmful in pregnancy.
However, because there is only very limited information on its
use in pregnancy, it's not generally recommended. If you think
you need to take Buscopan in pregnancy, talk to your doctor of
pharmacist who will help you decide, or may recommend other
medicines for you.
 SIDE EFFECTS
• Overdose may produce temporary paralysis of ciliary muscle,

• Pupillary dilation, Tachycardia, Palpitations, hot/dry/flushed skin, absence of

bowel sounds, hyperthermia,

• Increased respiratory rate,

• EKG abnormalities, Nausea, vomiting; rash over face/upper trunk,

• CNS stimulation, Psychosis (agitation, restlessness, rambling speech, visual

hallucinations, Paranoid behaviour, delusions) followed by depression.
 MIDWIFERY RESPONSIBILITY
• Before giving medication, instruct mother to avoid (reduces risk of urinary retention).
• Monitor daily pattern of bowel activity, stool consistency.
• Palpate bladder for urinary retention.
• Monitor changes in B/P, temperature.
• Assess skin turgor, mucous membranes to evaluate hydration status (encourage adequate
fluid intake) bowel sounds for peristalsis.
• Be alert for fever (increased risk of hyperthermia).
• May cause dry mouth; maintain good oral hygiene habits (lack of saliva may increase risk of
cavities).
• Inform physician of rash, eye pain, difficulty in urinating, constipation.
• Avoid tasks that require alertness, motor skills until response to drug is established.